Agustin Gago
Corporate Officer/Principal chez Syncromune, Inc.
Fortune : - $ au 30/04/2024
Postes actifs de Agustin Gago
Sociétés | Poste | Début | Fin |
---|---|---|---|
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | Corporate Officer/Principal | 01/01/2020 | - |
Historique de carrière de Agustin Gago
Anciens postes connus de Agustin Gago
Sociétés | Poste | Début | Fin |
---|---|---|---|
ImmunSYS, Inc.
ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL. | Corporate Officer/Principal | 01/01/2019 | 01/01/2020 |
INSPIREMD, INC. | Corporate Officer/Principal | 26/10/2016 | 30/09/2018 |
DELCATH SYSTEMS, INC. | Sales & Marketing | 03/11/2009 | 08/04/2013 |
E-Z-EM, Inc.
E-Z-EM, Inc. Medical SpecialtiesHealth Technology E-Z-EM, Inc. develops, manufactures and markets diagnostic imaging products. The firm's products are used for computed tomography and magnetic resonance imaging, colorectal cancer screening, evaluation of swallowing disorders and testing for other diseases, and disorders of the gastrointestinal system. The company was founded in 1961 and is headquartered in Lake Success, NY. | Corporate Officer/Principal | 01/01/2008 | 01/01/2008 |
VOYAGEUR PHARMACEUTICALS LTD. | Directeur/Membre du Conseil | - | - |
Dash International LLC
Dash International LLC Miscellaneous Commercial ServicesCommercial Services Dash International LLC provides business support services. The private company is based in Stevensville. The American company was founded by Agustin V. Gago. | Fondateur | 01/01/2013 | - |
Corporate Officer/Principal | 01/01/2013 | - | |
ANGIODYNAMICS, INC. | Sales & Marketing | 23/07/2008 | - |
Formation de Agustin Gago
Hofstra University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 8 |
Israël | 2 |
Canada | 2 |
Opérationnelle
Corporate Officer/Principal | 5 |
Sales & Marketing | 2 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 7 |
Consumer Services | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
ANGIODYNAMICS, INC. | Health Technology |
DELCATH SYSTEMS, INC. | Health Technology |
INSPIREMD, INC. | Health Technology |
VOYAGEUR PHARMACEUTICALS LTD. | Process Industries |
Entreprise privées | 4 |
---|---|
E-Z-EM, Inc.
E-Z-EM, Inc. Medical SpecialtiesHealth Technology E-Z-EM, Inc. develops, manufactures and markets diagnostic imaging products. The firm's products are used for computed tomography and magnetic resonance imaging, colorectal cancer screening, evaluation of swallowing disorders and testing for other diseases, and disorders of the gastrointestinal system. The company was founded in 1961 and is headquartered in Lake Success, NY. | Health Technology |
Dash International LLC
Dash International LLC Miscellaneous Commercial ServicesCommercial Services Dash International LLC provides business support services. The private company is based in Stevensville. The American company was founded by Agustin V. Gago. | Commercial Services |
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | Health Technology |
ImmunSYS, Inc.
ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL. | Health Technology |
- Bourse
- Insiders
- Agustin Gago
- Expérience